+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Somatostatin"

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • September 2024
  • 247 Pages
  • Global
From
Advanced Merkel cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Merkel cell carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Octreotide Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Octreotide Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Acromegaly - Pipeline Insight, 2024 - Product Thumbnail Image

Acromegaly - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Neuroendocrine Tumors Market - Product Thumbnail Image

Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Gastric Neuroendocrine Tumors Market - Product Thumbnail Image

Gastric Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
From
Somatostatin Receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Somatostatin Receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Neuroendocrine Carcinoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Acromegaly Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Acromegaly Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
From
Loading Indicator

Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer. Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production. Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more